<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">WJN</journal-id>
<journal-id journal-id-type="hwp">spwjn</journal-id>
<journal-id journal-id-type="nlm-ta">West J Nurs Res</journal-id>
<journal-title>Western Journal of Nursing Research</journal-title>
<issn pub-type="ppub">0193-9459</issn>
<issn pub-type="epub">1552-8456</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0193945911402848</article-id>
<article-id pub-id-type="publisher-id">10.1177_0193945911402848</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Measurement of Quality of Life in Menopausal Women</article-title>
<subtitle>A Systematic Review</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Shin</surname><given-names>Hyunjeong</given-names></name>
<xref ref-type="aff" rid="aff1-0193945911402848">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Shin</surname><given-names>Hye Sook</given-names></name>
<xref ref-type="aff" rid="aff1-0193945911402848">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0193945911402848"><label>1</label>Kyung Hee University, Seoul, Republic of Korea</aff>
<author-notes>
<corresp id="corresp1-0193945911402848">Hyunjeong Shin, College of Nursing Science, Kyung Hee University, 1 Hoegi-dong Dongdaemun-gu, Seoul 130-701, Republic of Korea Email: <email>98shj98@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>34</volume>
<issue>4</issue>
<fpage>475</fpage>
<lpage>503</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Use of a wide variety of quality of life (QoL) instruments, each measuring a different aspect of menopause with a different type of underlying scale, has been a major problem in menopause research. The aim of this review was to identify instruments developed for menopausal women and evaluate the psychometric properties and appropriateness of instruments for the study of QoL in menopausal women. Seven measures from 16 papers were chosen for the review. The psychometric evaluations were conducted based on quality judgment criteria. Of the seven measures reviewed in this study, the psychometric quality scores of Women’s Health Questionnaire (WHQ) was the highest. However, the result indicates that most instruments of menopause-specific QoL need further testing and evaluation of the various aspects of their psychometric properties. In addition, future research assessing psychometric properties with cross-cultural samples may be beneficial in adapting measures to specific context and study populations.</p>
</abstract>
<kwd-group>
<kwd>systematic review</kwd>
<kwd>quality of life</kwd>
<kwd>menopause</kwd>
<kwd>middle-aged</kwd>
<kwd>instrument</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Menopause is a natural transition encompassing not only the biological changes but also the social and cultural changes associated with the aging process (<xref ref-type="bibr" rid="bibr30-0193945911402848">Hunt, 2000</xref>; <xref ref-type="bibr" rid="bibr47-0193945911402848">Schneider, 2002</xref>; <xref ref-type="bibr" rid="bibr65-0193945911402848">Zöllner, Acquadro, &amp; Schaefer, 2005</xref>). It usually occurs sometime between 40 and 60 years and marks the end of the reproductive phase of a women’s life (<xref ref-type="bibr" rid="bibr40-0193945911402848">Mishra &amp; Kuh, 2010</xref>). The whole process of transition from premenopause to postmenopause may take more than 10 years (<xref ref-type="bibr" rid="bibr1-0193945911402848">Alder, 2002</xref>). During these years, many women experience physical changes including hot flushes, sleep disorders, fatigue, and sexual dysfunction as well as psychological changes, such as depression, anxiety, and irritability (<xref ref-type="bibr" rid="bibr17-0193945911402848">Freedman, 2002</xref>; <xref ref-type="bibr" rid="bibr40-0193945911402848">Mishra &amp; Kuh, 2010</xref>). All of these symptoms and experiences may affect the daily life of menopausal women (<xref ref-type="bibr" rid="bibr17-0193945911402848">Freedman, 2002</xref>).</p>
<p>Midlife women’s quality of life (QoL) may be impacted by adverse physical and mental health changes during the period of menopausal transition (<xref ref-type="bibr" rid="bibr16-0193945911402848">Elavsky, 2009</xref>). Especially, it has been found to have the most negative influence on QoL during the perimenopausal and early postmenopausal periods (<xref ref-type="bibr" rid="bibr32-0193945911402848">Jacobs, Hyland, &amp; Ley, 2000</xref>; <xref ref-type="bibr" rid="bibr35-0193945911402848">Li, Holm, Gulanick, &amp; Lanuza, 2000</xref>; <xref ref-type="bibr" rid="bibr55-0193945911402848">Utian, 2007</xref>). However, despite decades of research on menopause, how menopause influences women’s QoL and the relationship between QoL and menopause is a controversial subject (<xref ref-type="bibr" rid="bibr11-0193945911402848">Col, Haskins, &amp; Ewan-Whyte, 2009</xref>; <xref ref-type="bibr" rid="bibr65-0193945911402848">Zöllner et al., 2005</xref>). One of the factors contributing to this controversy is a failure to use adequately validated scales in menopause research (<xref ref-type="bibr" rid="bibr14-0193945911402848">Dennerstein &amp; Helmes, 2000</xref>). <xref ref-type="bibr" rid="bibr39-0193945911402848">Matthews and Bromberger (2005)</xref> indicated that a number of menopausal QoL measures which have been assessed for their validity are limited; some of them have measured only the frequency and severity of symptoms, and some have been used with homogeneous small samples. The variability and lack of standardization of the measuring methodology may reduce the ability to make direct cross-study comparisons (<xref ref-type="bibr" rid="bibr17-0193945911402848">Freedman, 2002</xref>; <xref ref-type="bibr" rid="bibr35-0193945911402848">Li et al., 2000</xref>).</p>
<p>This systematic review evaluates currently available menopause-specific QoL measures and compares instruments by psychometric criteria. It will help to determine the most suitable QoL measure for menopausal women reducing measurement error. Ultimately, it will allow us to study and understand QoL during menopausal transition more accurately, which can advance this area of study.</p>
<sec id="section1-0193945911402848">
<title>Measuring QoL During Menopausal Transition</title>
<p>QoL is an important endpoint in health-related research and improvement of it is one of the primary purposes of health promotion and care (<xref ref-type="bibr" rid="bibr50-0193945911402848">Schneider, MacLennan, &amp; Feeny, 2008</xref>). However, QoL measures have very different meanings although they may have the same levels (<xref ref-type="bibr" rid="bibr39-0193945911402848">Matthews &amp; Bromberger, 2005</xref>). Although we may believe that we understand the term <italic>quality of life</italic>, actually defining and measuring this concept has proven both difficult and confusing (<xref ref-type="bibr" rid="bibr55-0193945911402848">Utian, 2007</xref>). A lack of consensus on appropriate definitions has been one of the issues of measuring QoL in the research of menopause (<xref ref-type="bibr" rid="bibr35-0193945911402848">Li et al., 2000</xref>); authors consider QoL as a measurement of well-being, the use of health services, or an absence of menopausal symptoms (<xref ref-type="bibr" rid="bibr13-0193945911402848">Dennerstein, Dudley, &amp; Burger, 1997</xref>; <xref ref-type="bibr" rid="bibr35-0193945911402848">Li et al., 2000</xref>; <xref ref-type="bibr" rid="bibr55-0193945911402848">Utian, 2007</xref>). As a result, interpreting findings regarding the relationship between menopausal status and QoL has been hindered by issues related to the definition and measurement of QoL (<xref ref-type="bibr" rid="bibr40-0193945911402848">Mishra &amp; Kuh, 2010</xref>).</p>
<p>Although the term <italic>quality of life</italic> is not clearly defined, there is consensus that it refers to a multidimensional construct (<xref ref-type="bibr" rid="bibr37-0193945911402848">Manning-Walsh, 2005</xref>; <xref ref-type="bibr" rid="bibr50-0193945911402848">Schneider et al., 2008</xref>; <xref ref-type="bibr" rid="bibr64-0193945911402848">Yan &amp; Sellick, 2004</xref>; <xref ref-type="bibr" rid="bibr65-0193945911402848">Zöllner et al., 2005</xref>). <xref ref-type="bibr" rid="bibr65-0193945911402848">Zöllner et al. (2005)</xref> also mentioned that the notion of multidimensionality is a key component of menopausal QoL and the assessment of each domain goes beyond a mere counting of events. Most menopause-specific measures yield factor-derived subscales analytically determined (<xref ref-type="bibr" rid="bibr39-0193945911402848">Matthews &amp; Bromberger, 2005</xref>). The most important and universally accepted domains reflect physical, emotional, and social functioning (<xref ref-type="bibr" rid="bibr56-0193945911402848">Utian, Janata, Kingsberg, Schluchter, &amp; Hamilton, 2002</xref>; <xref ref-type="bibr" rid="bibr60-0193945911402848">Wiklund, 1998</xref>). A lot of measures contain domains of symptoms and perceptions of well-being as well as functioning (<xref ref-type="bibr" rid="bibr15-0193945911402848">Dinger, Zimmermann, Heinemann, &amp; Stoehr, 2006</xref>; <xref ref-type="bibr" rid="bibr29-0193945911402848">Hilditch et al., 1996</xref>; <xref ref-type="bibr" rid="bibr31-0193945911402848">Hunter, 1992</xref>). However, whether the aggregation of several dimensions into a summary index is appropriate still remains open to continuing debate (<xref ref-type="bibr" rid="bibr50-0193945911402848">Schneider et al., 2008</xref>).</p>
<p>Given the breadth of the concepts captured by QoL, it is not surprising that many types of measurement tools are available (<xref ref-type="bibr" rid="bibr39-0193945911402848">Matthews &amp; Bromberger, 2005</xref>). There are two major categories of QoL scales, generic measures and condition-specific measures. Generic measures are applicable to any type of population, but condition-specific measures are applicable to particular populations such as those afflicted with a particular health condition (<xref ref-type="bibr" rid="bibr50-0193945911402848">Schneider et al., 2008</xref>). It is known that condition-specific measures may be more sensitive or responsive to changes in the condition than generic measures, and more relevant to the concerns of clients who are in those conditions (<xref ref-type="bibr" rid="bibr4-0193945911402848">Brazier, Roberts, Platts, &amp; Zoellner, 2005</xref>).</p>
<p>However, condition-specific measures tend to focus on symptoms. As a consequence, respondents may tend to concentrate on the negative aspects of the condition, hence, neglecting other aspects of their lives unaffected by the condition (<xref ref-type="bibr" rid="bibr50-0193945911402848">Schneider et al., 2008</xref>). However, much of literature suggests that the symptoms do not completely explain the changes in QoL during menopausal transition (<xref ref-type="bibr" rid="bibr1-0193945911402848">Alder, 2002</xref>; <xref ref-type="bibr" rid="bibr2-0193945911402848">Anderson &amp; Burckhardt, 1999</xref>; <xref ref-type="bibr" rid="bibr11-0193945911402848">Col et al., 2009</xref>; <xref ref-type="bibr" rid="bibr55-0193945911402848">Utian, 2007</xref>). Menopause is not a disease that it is illogical to label as a disease condition that universally affects over half the population (<xref ref-type="bibr" rid="bibr1-0193945911402848">Alder, 2002</xref>; <xref ref-type="bibr" rid="bibr14-0193945911402848">Dennerstein &amp; Helmes, 2000</xref>). <xref ref-type="bibr" rid="bibr62-0193945911402848">Woods (2010)</xref> mentioned that QoL is not the menopausal symptom itself but the consequences of symptoms. In the study of menopause, QoL needs to be assessed beyond just determining the impact of symptoms experienced during menopause (<xref ref-type="bibr" rid="bibr40-0193945911402848">Mishra &amp; Kuh, 2010</xref>).</p>
<p>For application to the research, a scale must be reliable, valid, and sensitive or responsive to treatment-induced changes over time (<xref ref-type="bibr" rid="bibr60-0193945911402848">Wiklund, 1998</xref>). Although wide variety of instruments are in use, a number of menopause-specific measures that have been assessed for their psychometric properties are limited (<xref ref-type="bibr" rid="bibr39-0193945911402848">Matthews &amp; Bromberger, 2005</xref>). In addition, many measures are on a national rather than international basis and using disparate assessment periods and scoring methods (<xref ref-type="bibr" rid="bibr40-0193945911402848">Mishra &amp; Kuh, 2010</xref>). Two published reviews have provided a comprehensive summary of the menopausal QoL instruments (<xref ref-type="bibr" rid="bibr39-0193945911402848">Matthews &amp; Bromberger, 2005</xref>; <xref ref-type="bibr" rid="bibr65-0193945911402848">Zöllner et al., 2005</xref>) but have not critiqued fully the quality of measures using any psychometric criteria. Information about the psychometric properties of the instrument should be obtained and evaluated before the tool is selected for use (<xref ref-type="bibr" rid="bibr58-0193945911402848">Waltz, Strickland, &amp; Lenz, 2005</xref>). Thus, further evaluation of the accuracy of the measuring methods, along with a consensus in the research community on the appropriate tools to use in evaluating QoL issues related to menopause, will help to advance this area of study (<xref ref-type="bibr" rid="bibr17-0193945911402848">Freedman, 2002</xref>).</p>
</sec>
<sec id="section2-0193945911402848" sec-type="methods">
<title>Method</title>
<sec id="section3-0193945911402848">
<title>Aims</title>
<p>The aim of this review was to identify instruments developed specifically to measure QoL in menopausal women and evaluate the psychometric properties of the instruments.</p>
</sec>
<sec id="section4-0193945911402848">
<title>Design</title>
<p>A systematic review was conducted following the Center for Reviews and Dissemination guidelines on undertaking systematic reviews (<xref ref-type="bibr" rid="bibr6-0193945911402848">Center for Reviews and Dissemination, 2009</xref>) and review methods reported in the current systematic review literature (<xref ref-type="bibr" rid="bibr27-0193945911402848">Hek, Langton, &amp; Blunden, 2000</xref>; <xref ref-type="bibr" rid="bibr59-0193945911402848">Whiting, 2009</xref>).</p>
</sec>
<sec id="section5-0193945911402848">
<title>Search Methods</title>
<p>A systematic literature search was made of the CINAHL, OVID MEDLINE, and ScienceDirect databases using the keywords of <italic>menopause, midlife, middle-aged, quality of life</italic>, and <italic>health-related quality of life</italic>. The time frame of the search was from 1990 to 2009 to focus on instruments which were used in recent QoL studies. After each database was comprehensively searched, references of relevant publications were searched for further instruments or papers reporting the psychometric properties of identified instruments. An Internet search was also conducted to retrieve literature not available through usual databases. It was accomplished by combining psychometric terms (i.e., reliability, validity) with the names of identified instruments. The articles were found in the Internet search, with duplications occurring when using databases mentioned above. The following inclusion and exclusion criteria were used:</p>
<list id="list1-0193945911402848" list-type="simple">
<list-item><p>Inclusion criteria</p>
<list id="list2-0193945911402848" list-type="bullet">
<list-item><p>Original research articles</p></list-item>
<list-item><p>Studies including menopausal or midlife women as participants</p></list-item>
<list-item><p>Published in English between 1990 and 2009.</p></list-item></list></list-item>
<list-item><p>Exclusion criteria</p>
<list id="list3-0193945911402848" list-type="bullet">
<list-item><p>Unpublished manuscripts or doctoral dissertations (due to access constrained by cost)</p></list-item>
<list-item><p>Studies containing no original data</p></list-item>
<list-item><p>Review or opinion articles about measuring QoL in menopausal women</p></list-item></list></list-item></list>
</sec>
<sec id="section6-0193945911402848">
<title>Search Strategy</title>
<p>The initial search yielded 221 papers, which were reviewed by two reviewers. The process of selection based on inclusion and exclusion criteria is presented in <xref ref-type="fig" rid="fig1-0193945911402848">Figure 1</xref>. The initial review of the 221 studies was an abstract review. Based on the review of abstracts, 103 papers were excluded because they have the women with specific conditions (e.g., living alone, following renal transplantation, as the caregiver). We selected 118 papers for full-text review. From the 118 papers selected, 19 QoL instruments were retrieved. When a questionnaire was modified from its original version, it was reviewed as a separate instrument. Among them, 53 papers used either generic QoL measures (five measures) or disease-specific QoL measures (four measures). The remaining 65 papers used 10 menopause-specific QoL measures developed specifically for menopausal women or middle-aged women. As the focus of this review was menopause-specific QoL measures, 65 papers were reviewed again. Among them, 44 papers were excluded because they did not include scale properties and reliability/validity testing. Most of the excluded papers contained only Cronbach’s α coefficients of the measure. Thus, 21 papers remained.</p>
<fig id="fig1-0193945911402848" position="float">
<label>Figure 1.</label>
<caption>
<p>Flow diagram of the study selection process</p>
</caption>
<graphic xlink:href="10.1177_0193945911402848-fig1.tif"/>
</fig>
</sec>
<sec id="section7-0193945911402848">
<title>Search Outcome</title>
<p>The search resulted in 21 papers with 9 instruments meeting inclusion and exclusion criteria outlined above. Among the retrieved 21 papers, 5 papers using two instruments (Cervantes Health-Related Quality of Life and Greene Climacteric Scale) were excluded because development and validation studies of one measure, Cervantes Health-Related Quality of Life, were written in Spanish (<xref ref-type="bibr" rid="bibr36-0193945911402848">Llaneza et al., 2007</xref>). With regard to the other, Greene Climacteric Scale (<xref ref-type="bibr" rid="bibr23-0193945911402848">Greene, 1998</xref>) was primarily developed to measure climacteric symptoms rather than QoL (<xref ref-type="bibr" rid="bibr14-0193945911402848">Dennerstein &amp; Helmes, 2000</xref>; <xref ref-type="bibr" rid="bibr23-0193945911402848">Greene, 1998</xref>). Although it has been used to measure QoL in some studies, it was not validated as the QoL measure and has been usually used to measure the severity of menopausal symptoms rather than QoL in much of the research (<xref ref-type="bibr" rid="bibr3-0193945911402848">Barentsen, van de Weijer, van Gend, &amp; Foekema, 2001</xref>; <xref ref-type="bibr" rid="bibr7-0193945911402848">Chattha, Kulkarni, Nagarathna, &amp; Nagendra, 2008</xref>; <xref ref-type="bibr" rid="bibr10-0193945911402848">Chung &amp; Tang, 2006</xref>; <xref ref-type="bibr" rid="bibr20-0193945911402848">Gharaibeh, Al-Obeisat, &amp; Hattab, 2010</xref>; <xref ref-type="bibr" rid="bibr54-0193945911402848">Travers, O’Neill, King, Battistutta, &amp; Khoo, 2005</xref>). Finally, 16 papers with 7 measures were chosen for the analysis.</p>
<p>The relevance of the retrieved papers was assessed by the first author and then checked by the second author. Disagreement (2 among 16 papers) was handled by checking the full contents of the papers and further discussion. Therefore, all 16 papers retrieved were included in the review. Then, the papers retrieved were grouped by validated instrument for the purpose of synthesizing psychometric properties. Four measures were matched with each retrieved paper. Three measures were matched with 2 to 5 retrieved papers, respectively.</p>
</sec>
<sec id="section8-0193945911402848">
<title>Quality Appraisal of Selected Instruments</title>
<p>The quality appraisal criteria were fundamentally based on the instrument used in previous review studies (<xref ref-type="bibr" rid="bibr45-0193945911402848">Pudas-Tahka, Axelin, Aantaa, Lund, &amp; Salantera, 2009</xref>; <xref ref-type="bibr" rid="bibr66-0193945911402848">Zwakhalen, Hamers, Abu-Saad, &amp; Berger, 2006</xref>). Originally, it was developed to compare pain assessment tools (<xref ref-type="bibr" rid="bibr66-0193945911402848">Zwakhalen et al., 2006</xref>), consisting of 10 items. Thus, some items which were not adequate for the present review were modified. For instance, interrater and intrarater reliability were removed because they were not necessary for self-report QoL instruments while factorial validity was included because of multidimensionality of the concept.</p>
<p>For this review, responsiveness was also included as an item of psychometric criteria. It is indicated when a measure is sensitive to changes over time or detects changes in outcome following an intervention or event (<xref ref-type="bibr" rid="bibr18-0193945911402848">Garvie, Lawford, Banet, &amp; West, 2009</xref>). Thus, considerations of responsiveness are important and it has been used as one of the psychometric evaluation criteria for QoL instruments (<xref ref-type="bibr" rid="bibr18-0193945911402848">Garvie et al., 2009</xref>; <xref ref-type="bibr" rid="bibr22-0193945911402848">Grange, Bekker, Noyes, &amp; Langley, 2007</xref>; <xref ref-type="bibr" rid="bibr42-0193945911402848">Pearce, Sanson-Fisher, &amp; Campbell, 2008</xref>). Several statistical approaches are used to assess responsiveness, including effect size, change scores, and sensitivity/specificity (<xref ref-type="bibr" rid="bibr42-0193945911402848">Pearce et al., 2008</xref>).</p>
<p>Ultimately, the total number of evaluation item was 10 and every item received points from 0 to 2 with a total range of 0 to 20. The scoring system is based on <xref ref-type="bibr" rid="bibr66-0193945911402848">Zwakhalen et al.’s (2006)</xref> study and was somewhat modified based on previous psychometric reviews and psychometric literature (<xref ref-type="bibr" rid="bibr22-0193945911402848">Grange et al., 2007</xref>; <xref ref-type="bibr" rid="bibr57-0193945911402848">van Saane, Sluiter, Verbeek, &amp; Frings-Dresen, 2003</xref>; <xref ref-type="bibr" rid="bibr58-0193945911402848">Waltz et al., 2005</xref>). The higher the score, the better quality the measure is. The quality criteria are summarized in <xref ref-type="table" rid="table1-0193945911402848">Table 1</xref>.</p>
<table-wrap id="table1-0193945911402848" position="float">
<label>Table 1.</label>
<caption>
<p>Psychometric Quality Appraisal Criteria in This Study</p>
</caption>
<graphic alternate-form-of="table1-0193945911402848" xlink:href="10.1177_0193945911402848-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Psychometric Aspects</th>
<th align="center">Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td>Target population of validation study</td>
<td>2: <italic>N</italic> ≥ 200 and includes pre-, peri-, and postmenopausal women</td>
</tr>
<tr>
<td/>
<td>1: 100 ≤ <italic>N</italic> &lt; 200 or includes only postmenopausal women</td>
</tr>
<tr>
<td/>
<td>0: <italic>N</italic> &lt; 100</td>
</tr>
<tr>
<td>Responsiveness</td>
<td>2: Effect size or responsiveness index ≥ 0.8, significant differences between pre- and posttreatment in the majority of scores including total score, or sensitivity/specificity ≥70%</td>
</tr>
<tr>
<td/>
<td>1: 0.5 ≤ effect size or responsiveness index &lt; 0.8, no significant differences in several domain scores between pre- and posttreatment, or 50% ≤ sensitivity/specificity &lt; 70%</td>
</tr>
<tr>
<td/>
<td>0: Effect size or responsiveness index &lt; 0.5, no significant differences in all domain scores between pre- and posttreatment, or no information</td>
</tr>
<tr>
<td>Cronbach’s α</td>
<td>2: α for total score (if in the absence of the total score, range for each domain) ≥ 0.80</td>
</tr>
<tr>
<td/>
<td>1: 0.70 ≤ α &lt; 0.80</td>
</tr>
<tr>
<td/>
<td>0: α &lt; .70 or no information</td>
</tr>
<tr>
<td>Test–retest reliability</td>
<td>2: Coefficient for total score (if in the absence of the total score, coefficient range for each domain) ≥ 0.80</td>
</tr>
<tr>
<td/>
<td>1: 0.70 ≤ coefficient &lt; 0.80</td>
</tr>
<tr>
<td/>
<td>0: Coefficient &lt; 0.70 or no information</td>
</tr>
<tr>
<td>Item analysis</td>
<td>2: 0.3 ≤ interitem correlation coefficients &lt; 0.7 or 0.3 ≤ item-total correlation coefficients</td>
</tr>
<tr>
<td/>
<td>1: Interitem correlation coefficients &lt; 0.3 or ≥ 0.7, or item-total correlation coefficients &lt; 0.3</td>
</tr>
<tr>
<td/>
<td>0: Correlations are not significant or not examined</td>
</tr>
<tr>
<td>Item generation (face/content validity)</td>
<td>2: Specifically collected from menopausal women or face validity or content validity was established</td>
</tr>
<tr>
<td/>
<td>1: Generated only through literature and research support or by modification of existing instruments</td>
</tr>
<tr>
<td/>
<td>0: Originated from another population or no information</td>
</tr>
<tr>
<td>Factorial validity</td>
<td>2: Dimensional structures were congruent with factors statistically identified</td>
</tr>
<tr>
<td/>
<td>1: Dimensional structures were not congruent with factors statistically identified</td>
</tr>
<tr>
<td/>
<td>0: Not examined</td>
</tr>
<tr>
<td>Convergent validity in relation to similar or same construct</td>
<td>2: Correlation coefficients for total score (if in the absence of the total score, coefficient range for each domain) ≥ 0.6</td>
</tr>
<tr>
<td/>
<td>1: 0.4 ≤ Correlation coefficients &lt; 0.6</td>
</tr>
<tr>
<td/>
<td>0: Correlation coefficients &lt; 0.4 or no information</td>
</tr>
<tr>
<td>Discriminant validity in relation to similar but different construct</td>
<td>2: Correlation coefficients (for total score or most domains) &lt;0.5</td>
</tr>
<tr>
<td/>
<td>1: Correlation coefficients (for several domains) ≥ 0.5</td>
</tr>
<tr>
<td/>
<td>0: No information or no significant correlations</td>
</tr>
<tr>
<td>Known-groups validity</td>
<td>2: Significant differences between known groups in the majority of scores including total score</td>
</tr>
<tr>
<td/>
<td>1: No significant differences in several domain scores between known groups</td>
</tr>
<tr>
<td/>
<td>0: No significant difference in total score or no information</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="section9-0193945911402848" sec-type="results">
<title>Results</title>
<p>All of papers retained were quantitative studies that described the psychometric properties of the individual instrument. They were published between 1992 and 2008, with the majority (<italic>n</italic> = 13) published after 2000. The majority (<italic>n</italic> = 13) of papers are psychometric studies. Remaining three papers are an experimental study, a comparative study, and a cross-sectional descriptive study, respectively.</p>
<p>Seven measures were identified in the 16 papers: Women’s Health Questionnaire (WHQ; <xref ref-type="bibr" rid="bibr19-0193945911402848">Genazzani et al., 2002</xref>; <xref ref-type="bibr" rid="bibr31-0193945911402848">Hunter, 1992</xref>; <xref ref-type="bibr" rid="bibr44-0193945911402848">Progetto Donna Qualita della Vita Working Group et al., 2002</xref>; <xref ref-type="bibr" rid="bibr61-0193945911402848">Wiklund et al., 1992</xref>; <xref ref-type="bibr" rid="bibr63-0193945911402848">Wool et al., 2000</xref>), Menopause Rating Scale (MRS; <xref ref-type="bibr" rid="bibr15-0193945911402848">Dinger et al., 2006</xref>; <xref ref-type="bibr" rid="bibr26-0193945911402848">Heinemann et al., 2004</xref>; <xref ref-type="bibr" rid="bibr48-0193945911402848">Schneider, Heinemann, Rosemeier, Potthoff, &amp; Behre, 2000a</xref>, <xref ref-type="bibr" rid="bibr49-0193945911402848">2000b</xref>; <xref ref-type="bibr" rid="bibr51-0193945911402848">Schneider, Rosemeier, Schnitker, Gerbsch, &amp; Turck, 2000</xref>), Menopause-specific Quality of Life Questionnaire (MENQOL; <xref ref-type="bibr" rid="bibr8-0193945911402848">Chen, Lin, Wei, Gao, &amp; Wu, 2007</xref>; <xref ref-type="bibr" rid="bibr29-0193945911402848">Hilditch et al., 1996</xref>), Menopausal Quality of Life (MQOL; <xref ref-type="bibr" rid="bibr32-0193945911402848">Jacobs et al., 2000</xref>), the MENCAV (<xref ref-type="bibr" rid="bibr5-0193945911402848">Buendia Bermejo et al., 2008</xref>), Utian Quality of Life Scale (UQOL; <xref ref-type="bibr" rid="bibr56-0193945911402848">Utian et al., 2002</xref>), and MENQOL-Intervention (<xref ref-type="bibr" rid="bibr34-0193945911402848">Lewis, Hilditch, &amp; Wong, 2005</xref>). Among them, MENQOL-Intervention is a modified version of the MENQOL to ensure that side effects of specific therapies that might adversely affect QoL were reflected in the outcome measure (<xref ref-type="bibr" rid="bibr34-0193945911402848">Lewis et al., 2005</xref>).</p>
<p>The reporting of the review results focuses on evaluating the measures in terms of (a) characteristics of the instruments and study participants, (b) psychometric rigor including reliability and validity, (c) responsiveness, (d) and quality scores of the reviewed instruments.</p>
<sec id="section10-0193945911402848">
<title>Characteristics of the Instrument and Participants</title>
<p>Detailed findings of characteristics of the instruments are summarized in <xref ref-type="table" rid="table2-0193945911402848">Table 2</xref>. All of the instruments evaluated were self-report scales. Four measures were developed in Europe (United Kingdom, <italic>n</italic> = 2; Germany, <italic>n</italic> = 1; Spain, <italic>n</italic> = 1) with the remaining originating in Canada (<italic>n</italic> = 2) and the United States (<italic>N</italic> = 1).</p>
<table-wrap id="table2-0193945911402848" position="float">
<label>Table 2.</label>
<caption>
<p>Characteristics and Total Quality Appraisal Scores of Menopause-Specific QoL Measures</p>
</caption>
<graphic alternate-form-of="table2-0193945911402848" xlink:href="10.1177_0193945911402848-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">WHQ</th>
<th align="center">MRS</th>
<th align="center">MENQOL</th>
<th align="center">MQOL</th>
<th align="center">MENCAV</th>
<th align="center">UQOL</th>
<th align="center">MENQOL-Intervention</th>
</tr>
</thead>
<tbody>
<tr>
<td>Country of origin</td>
<td>United Kingdom</td>
<td>Germany</td>
<td>Canada</td>
<td>United Kingdom</td>
<td>Spain</td>
<td>United States</td>
<td>Canada</td>
</tr>
<tr>
<td>Scaling</td>
<td>4-point rating scale</td>
<td>5-point rating scale</td>
<td>7-point Likert scale</td>
<td>1-6 response format</td>
<td>5-point Likert scale</td>
<td>5-point Likert scale</td>
<td>7-point Likert scale</td>
</tr>
<tr>
<td>Time to complete (min)</td>
<td>5-10</td>
<td align="center">—</td>
<td align="center">—</td>
<td align="center">—</td>
<td>11</td>
<td>A few minutes</td>
<td align="center">—</td>
</tr>
<tr>
<td>Domains covered (No. of items)</td>
<td><list list-type="simple">
<list-item><p>Nine domains (36)</p>
<list list-type="bullet">
<list-item><p>Depressed mood (7)</p></list-item>
<list-item><p>Somatic symptoms (7)</p></list-item>
<list-item><p>Memory/concentration (3)</p></list-item>
<list-item><p>Vasomotor symptoms (2)</p></list-item>
<list-item><p>Anxiety/fears (4)</p></list-item>
<list-item><p>Sexual behavior (3)</p></list-item>
<list-item><p>Sleep problems (3)</p></list-item>
<list-item><p>Menstrual symptoms (4)</p></list-item>
<list-item><p>Attractiveness (2)</p></list-item>
</list></list-item>
</list></td>
<td><list list-type="simple">
<list-item><p>Three domains (11)</p>
<list list-type="bullet">
<list-item><p>Psychological symptoms (4)</p></list-item>
<list-item><p>Somatic-vegetative symptoms (4)</p></list-item>
<list-item><p>Urogenital symptoms (3)</p></list-item>
</list></list-item></list></td>
<td><list list-type="simple">
<list-item><p>Four domains (29)</p>
<list list-type="bullet">
<list-item><p>Physical (16)</p></list-item>
<list-item><p>Vasomotor (3)</p></list-item>
<list-item><p>Psychosocial (7)</p></list-item>
<list-item><p>Sexual (3)</p></list-item></list></list-item></list></td>
<td>
<list list-type="simple">
<list-item><p>Seven domains (48)</p>
<list list-type="bullet">
<list-item><p>Sleep (3)</p></list-item>
<list-item><p>Energy (10)</p></list-item>
<list-item><p>Cognition (5)</p></list-item>
<list-item><p>Symptoms impact (10)</p></list-item>
<list-item><p>Feelings (12)</p></list-item>
<list-item><p>Social interaction (7)</p></list-item>
<list-item><p>Appetite (1)</p></list-item>
</list></list-item></list></td>
<td>
<list list-type="simple">
<list-item><p>Five domains (35)</p>
<list list-type="bullet">
<list-item><p>Physical health (10)</p></list-item>
<list-item><p>Mental health (9)</p></list-item>
<list-item><p>Sexual relations (4)</p></list-item>
<list-item><p>Partner relationship (4)</p></list-item>
<list-item><p>Social support (8)</p></list-item>
</list></list-item></list></td>
<td>
<list list-type="simple">
<list-item><p>Four domains (23)</p>
<list list-type="bullet">
<list-item><p>Occupational (7)</p></list-item>
<list-item><p>Health (7)</p></list-item>
<list-item><p>Emotional (6)</p></list-item>
<list-item><p>Sexual (3)</p></list-item>
</list></list-item></list></td>
<td><list list-type="simple">
<list-item><p>Four domains (32)</p>
<list list-type="bullet">
<list-item><p>Physical (19)</p></list-item>
<list-item><p>Vasomotor (3)</p></list-item>
<list-item><p>Psychosocial (7)</p></list-item>
<list-item><p>Sexual (3)</p></list-item>
</list></list-item></list></td>
</tr>
<tr>
<td>Time frame covered</td>
<td>Past few days</td>
<td>At the moment</td>
<td>In the past month</td>
<td>At the moment</td>
<td>In the past 4 months</td>
<td>In the past month</td>
<td>In the past week</td>
</tr>
<tr>
<td>Total quality score</td>
<td>14</td>
<td>8</td>
<td>8</td>
<td>12</td>
<td>11</td>
<td>11</td>
<td>7</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0193945911402848">
<p>Note: QoL = quality of life; WHQ = Women’s Health Questionnaire; MRS = Menopause Rating Scale; MENQOL = Menopause-specific Quality of Life Questionnaire;</p>
</fn>
<fn id="table-fn2-0193945911402848">
<p>MQOL = Menopausal Quality of Life; MENCAV = the MENCAV menopause quality of life scale; UQOL = Utian Quality of Life scale; MENQOL-Intervention = Menopause-specific Quality of Life Questionnaire–Intervention.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The number of covering domains ranged from 3 (MRS) to 9 (WHQ). All measures include physical and psychological domains as common elements. Five of the seven instruments (WHQ, MENQOL, UQOL, MENQOL-Intervention, and the MENCAV) have the domain covering sexual health. No measure used a theoretical basis for selection of the domains.</p>
<p>The number of items per measure ranged from 11 (MRS) to 48 (MQOL). Three measures (WHQ, UQOL, and the MENCAV) reported time taken for completion of the questionnaire; times ranged from 5 min to 11 min.</p>
<p>All reported sample size and target population of the validation studies (<xref ref-type="table" rid="table3-0193945911402848">Table 3</xref>). The number of study participants ranged from 73 (MENQOL-Intervention) to 10,501 (MRS). In most studies, target populations were midlife women aged 40 to 65 years. However, validation studies for two measures (MENQOL and MENQOL-Intervention) included only postmenopausal women. Four studies validating WHQ and MRS reported mean or median ages (49.0-53.9 years) instead of the age range of the participants.</p>
<table-wrap id="table3-0193945911402848" position="float">
<label>Table 3.</label>
<caption>
<p>Target Population of Validation Study and Quality Appraisal Scores for Menopause-Specific QoL Measures</p>
</caption>
<graphic alternate-form-of="table3-0193945911402848" xlink:href="10.1177_0193945911402848-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">WHQ</th>
<th align="center">MRS</th>
<th align="center">MENQOL</th>
<th align="center">MQOL</th>
<th align="center">MENCAV</th>
<th align="center">UQOL</th>
<th align="center">MENQOL-Intervention</th>
</tr>
</thead>
<tbody>
<tr>
<td>Targetpopulationof validationstudy</td>
<td>• Midlife women in the United Kingdom (no HRT; 45-65 years; <italic>n</italic> = 682)</td>
<td>• For reliability and convergent validity: a random sample of 683 German women (40-60 years; <italic>n</italic> = 306)</td>
<td>• Canadian women 2-7 years postmenopause with a uterus (No HRT; 47-62 years; <italic>n</italic> = 88)</td>
<td>Menopausal women in the United Kingdom (40-63 years; <italic>n</italic> = 1,188)</td>
<td>Middle-aged Spanish women (40-60 years; <italic>n</italic> = 470)</td>
<td>Peri- and postmenopausal American women (45-65 years; <italic>n</italic> = 597)</td>
<td>Canadian women 1-8 years postmenopause with a uterus (41-61 years; <italic>n</italic> = 73)</td>
</tr>
<tr>
<td/>
<td>• Swedish postmenopausal women (mean age: 53.0 years; <italic>n</italic> = 136)</td>
<td>• For responsiveness test: German women who required HRT (mean age: 49.8 years; <italic>n</italic> =9,311)</td>
<td>• Peri- and postmenopausal</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>• Italian postmenopausal women (37-65 years, mean age: 54 years; <italic>n</italic> = 155)</td>
<td>• For factorial validity: pre- and postmenopausal German women (median age: 49 years; <italic>n</italic> = 10,501)</td>
<td>• Chinese women (40-60 years, mean age: 51.2 years; <italic>n</italic> = 353)</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>• Italian menopausal women (45-65 years; <italic>n</italic> = 928)</td>
<td>• For new validation: German women who required HRT (mean age: 53.9 years; <italic>n</italic> = 3,282)</td>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>• Italian postmenopausal women (n = 2,160)</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>2</td>
<td>2</td>
<td>0</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0193945911402848">
<p>Note: QoL = quality of life; WHQ = Women’s Health Questionnaire; MRS = Menopause Rating Scale; MENQOL = Menopause-specific Quality of Life Questionnaire; MQOL = Menopausal Quality of Life; MENCAV = the MENCAV menopause quality of life scale; UQOL = Utian Quality of Life scale; MENQOL-Intervention = Menopause-specific Quality of Life Questionnaire–Intervention; HRT = hormone replacement therapy.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-0193945911402848">
<title>Psychometric Assessment</title>
<sec id="section12-0193945911402848">
<title>Reliability</title>
<p>As shown in <xref ref-type="table" rid="table4-0193945911402848">Table 4</xref>, the authors of six measures (WHQ, MENQOL, MQOL, the MENCAV, UQOL, and MENQOL-Intervention) reported internal reliability using Cronbach’s α coefficient. It was greater than 0.70 for all six instruments. Reproducibility, using correlation coefficients between two time points (range: 3 days-18 months), was reported for six measures (WHQ, MRS, MENQOL, the MENCAV, UQOL, and MENQOL-Intervention) and ranged between 0.49 and 0.96. Four (MENQOL, the MENCAV, UQOL, and MENQOL-Intervention) of these reported values above 0.70 and two (WHQ and MRS) reported values below the minimum 0.70 criteria. Interitem or item-total correlations were examined in only two studies (WHQ and the MENCAV) meeting the criteria.</p>
<table-wrap id="table4-0193945911402848" position="float">
<label>Table 4.</label>
<caption>
<p>Psychometric Quality Appraisal for Reliability of Menopause-Specific QoL Measures</p>
</caption>
<graphic alternate-form-of="table4-0193945911402848" xlink:href="10.1177_0193945911402848-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">WHQ</th>
<th align="center">MRS</th>
<th align="center">MENQOL</th>
<th align="center">MQOL</th>
<th align="center">MENCAV</th>
<th align="center">UQOL</th>
<th align="center">MENQOL-Intervention</th>
</tr>
</thead>
<tbody>
<tr>
<td>Internal consistency (Cronbach’s α)</td>
<td>• 0.89 for total score, 0.41-0.82 for each domain</td>
<td align="center">—</td>
<td>• 0.81-0.89 for each domain</td>
<td>• 0.92 for total score</td>
<td>0.89 for total score, 0.71-0.91 for each domain</td>
<td>0.83 for total score, 0.64- 0.84 for each domain</td>
<td>0.72-0.88 for each domain</td>
</tr>
<tr>
<td/>
<td>• 0.88 for total score, 0.53-0.68 for each domain (Italian version)</td>
<td/>
<td>• 0.86-0.89 for each domain (Chinese version)</td>
<td>• 0.69-0.91 for each domain</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>• 0.56-0.78 for each domain (Italian version)</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>2</td>
<td>0</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>1</td>
</tr>
<tr>
<td>Test–retest reliability correlation coefficient (retest time frame)</td>
<td>• 0.69-0.96 for each domain (2 weeks)</td>
<td>0.60 for total score (18 months)</td>
<td>• ICC: 0.78 for total score, 0.69-0.81 for each domain</td>
<td align="center">—</td>
<td>• ICC: 0.77 for total score, 0.64-0.75 f each domain</td>
<td>• 0.89 for total score,</td>
<td>ICC: 0.79 for total score, 0.73-0.83 for each domain (14 days)</td>
</tr>
<tr>
<td/>
<td>• 0.78-0.85 for each domain (Italian version; 7 days)</td>
<td/>
<td>• Pearson correlation coefficient: 0.81-0.85 for each domain (1 month)</td>
<td/>
<td>• Spearman correlation coefficient: 0.75 for total score,</td>
<td>• 0.77-0.88 for each domain (3-7 days)</td>
<td/>
</tr>
<tr>
<td/>
<td>• ICC: 0.67-0.88 for each domain (Italian version; 7 days)</td>
<td/>
<td/>
<td/>
<td>• 0.49-0.71 for each domain (2 weeks)</td>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>2</td>
<td>1</td>
</tr>
<tr>
<td>Item analysis</td>
<td>Item-total correlation: 0.15-0.54</td>
<td align="center">—</td>
<td align="center">—</td>
<td align="center">—</td>
<td>• Mean interitem correlation for each domain: 0.23-0.53</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td>• Item-total correlation: 0.15-0.70</td>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0193945911402848">
<p>Note: QoL = quality of life; WHQ = Women’s Health Questionnaire; MRS = Menopause Rating Scale; MENQOL = Menopause-specific Quality of Life Questionnaire; MQOL = Menopausal Quality of Life; MENCAV = the MENCAV menopause quality of life scale; UQOL = Utian Quality of Life scale; MENQOL-Intervention = Menopause-specific Quality of Life Questionnaire – Intervention; ICC = intraclass correlation coefficient.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section13-0193945911402848">
<title>Validity</title>
<p>Detailed findings of quality of appraisal for validity of the instruments are summarized in <xref ref-type="table" rid="table5-0193945911402848">Table 5</xref>. Two measures (MQOL and UQOL) reported that their items were generated from interviews or focus group meetings with menopausal women. Four (WHQ, MRS, MENQOL, and MENQOL-Intervention) reported that their measures’ items were obtained through reference to experts or author opinion, evidence from relevant research, and/or existing scales. The item generation process of one measure (the MENCAV) was not available in English. Only the papers for UQOL mentioned sense of well-being as a theoretical basis for instrument development. Face validity of measures was reported in two studies (for MENQOL and MENQOL-Intervention) demonstrating good scores. Content validity of measures was rarely described in publications.</p>
<table-wrap id="table5-0193945911402848" position="float">
<label>Table 5.</label>
<caption>
<p>Psychometric Quality Appraisal for Validity of Menopause-Specific QoL Measures</p>
</caption>
<graphic alternate-form-of="table5-0193945911402848" xlink:href="10.1177_0193945911402848-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">WHQ</th>
<th align="center">MRS</th>
<th align="center">MENQOL</th>
<th align="center">MQOL</th>
<th align="center">MENCAV</th>
<th align="center">UQOL</th>
<th align="center">MENQOL-Intervention</th>
</tr>
</thead>
<tbody>
<tr>
<td>Item generation (face/content validity)</td>
<td>Research support of symptoms during menopause and existing anxiety and depression scale</td>
<td>Physician’s summary of the severity of climacteric complaints</td>
<td>• Literature, existing menopause and QOL questionnaires, and the clinical experience of the investigators and consultants</td>
<td>Results from interviews and focus groups with middle-aged women (40-60 years)</td>
<td>Not available in English</td>
<td>Theoretical basis: Incorporation of sense of well-being into an assessment tool and the result from focus group meetings with menopausal women</td>
<td>• Three items were added on physical domain of MENQOL to make more suitable for use when testing the effect of an intervention</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>• Face validity (postmenopause women; score was 4.7 out of a possible 5)</td>
<td/>
<td/>
<td/>
<td>• Face validity (postmenopause women; score was 4.5 out of a possible 5)</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>• Good content validity (expert panel)</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>1</td>
<td>1</td>
<td>2</td>
<td>2</td>
<td>0</td>
<td>2</td>
<td>2</td>
</tr>
<tr>
<td>Factorial validity</td>
<td>Exploratory factor analysis: 9 factors (original version) and 10 factors (Italian version)</td>
<td>Exploratory factor analysis: three factors</td>
<td align="center">—</td>
<td>Exploratory factor analysis: seven factors</td>
<td>Confirmatory factor analysis: five factors</td>
<td>Exploratory factor analysis: four factors</td>
<td align="center">—</td>
</tr>
<tr>
<td>Quality score</td>
<td>2</td>
<td>2</td>
<td>0</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>0</td>
</tr>
<tr>
<td>Known-groups validity</td>
<td>• All domain scores (except sleep problems domain) discriminate among menopausal status (Italian version)</td>
<td align="center">—</td>
<td align="center">—</td>
<td>Scores were significantly different among the different menopausal status (except in appetite domain)</td>
<td>Several domains and total scores discriminate between menopausal and nonmenopausal women (partner relationship and social support domain did not discriminate between the two groups)</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td/>
<td>• Seven domain scores discriminate between hormone users and nonusers (Italian version)</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>2</td>
<td>0</td>
<td>0</td>
<td>2</td>
<td>2</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Convergent validity</td>
<td>• Depression mood domain and GHQ, r = .81</td>
<td><list list-type="simple">
<list-item><p>Correlations</p>
<list list-type="bullet">
<list-item><p>with Kupperman Index, r = .91</p></list-item>
</list></list-item></list></td>
<td align="center">—</td>
<td>Correlation with GQOL, r = .61</td>
<td>• Physical health domain and SF-36 physical component, r = .48</td>
<td><list list-type="simple">
<list-item><p>Correlations</p>
<list list-type="bullet">
<list-item><p>Between health domain and SF-36 general health perception domain, r = .55</p></list-item>
</list></list-item></list></td>
<td><list list-type="simple">
<list-item><p>Correlations of</p>
<list list-type="bullet">
<list-item><p>Vasomotor domain score with BKI “hot flushed” item, r = .56</p></list-item>
</list></list-item></list></td>
</tr>
<tr>
<td/>
<td>• Anxiety domain and GHQ, r = .46</td>
<td>• with SF-36 somatic domain<sup><xref ref-type="table-fn" rid="table-fn6-0193945911402848">a</xref></sup>, r =−.48</td>
<td/>
<td/>
<td>• Mental health domain and SF-36 mental component, r = .72</td>
<td>• Between emotional domain and SF-36 mental components, r = .51</td>
<td>• Vasomotor domain score with BKI “sweating” item, r = .71</td>
</tr>
<tr>
<td/>
<td>• Total score and Kupperman Index, r = .82</td>
<td>• with SF-36 psychological domain<sup><xref ref-type="table-fn" rid="table-fn6-0193945911402848">a</xref></sup>, r = −.73</td>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>• Each domain and Kupperman Index, r = .28-.72</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>• Each domain and SF-36 domains, r = 0.11-0.73 (Italian version)</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>• Each domain and Kupperman Index, r = .00-.44 (partially significant; Italian version)</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>2</td>
<td>1</td>
<td>0</td>
<td>2</td>
<td>1</td>
<td>1</td>
<td>1</td>
</tr>
<tr>
<td>Discriminant validity</td>
<td align="center">—</td>
<td align="center">—</td>
<td><list list-type="bullet">
<list-item><p>Physical domain and Menopause Symptom Checklist, somatic and psychosomatic subscale, r = .69</p></list-item>
<list-item><p>Vasomotor domain and somatic subscale, r = .40</p></list-item></list></td>
<td align="center">—</td>
<td align="center">—</td>
<td align="center">—</td>
<td align="center">—</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>• Vasomotor domain and intensity of hot flushes, r = .40</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>• Psychosocial domain and psychologic subscale, r = .65</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>• Psychosocial domain and General Well-Being Schedule<sup><xref ref-type="table-fn" rid="table-fn7-0193945911402848">b</xref></sup>, r = −.70</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>• Sexual domain and Vaginal Symptoms Score, r = .38</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>• Sexual domain and Libido Index, r = .48</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0193945911402848">
<p>Note: QoL = quality of life; WHQ = Women’s Health Questionnaire; MRS = Menopause Rating Scale; MENQOL = Menopause-specific Quality of Life Questionnaire; MQOL = Menopausal Quality of Life; MENCAV = the MENCAV menopause quality of life scale; UQOL = Utian Quality of Life scale; MENQOL-Intervention = Menopause-specific Quality of Life Questionnaire – Intervention; GHQ = General Health Questionnaire; SF-36 = Short Form-36; GQOL = Global Quality of Life questionnaire; BKI = Blatt-Kupperman Index.</p>
</fn>
<fn id="table-fn6-0193945911402848">
<label>a</label>
<p>General Well-Being Schedule and MENQOL scores move in opposite directions.</p>
</fn>
<fn id="table-fn7-0193945911402848">
<label>b</label>
<p>SF-36 and MRS scores move in opposite directions.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>All measures reported evidence for construct validity. Five (WHQ, MRS, MQOL, the MENCAV, and UQOL) of them used more than one technique to establish construct validity. The most frequently reported method of examining construct validity was convergent validity. The authors of six measures (WHQ, MRS, MQOL, the MENCAV, UQOL, and MENQOL-Intervention) evaluated it by assessing the relationship between scores on their measure with scores on a measure of a similar construct. Two measures (WHQ and MQOL) reported coefficients above the recommended 0.60 level for the total score. Discriminant validity was investigated only in one measure (MENQOL) assessing the relationship between scores on the reviewed measure and scores on a measure of a similar but different construct. Two of the four domains in that measure (vasomotor and sexual domain) showed coefficients below 0.50 meeting criteria. Known-groups validity was examined in three measures (WHQ, MQOL, and the MENCAV) assessing whether scores distinguished between hormone therapy users and nonusers or among the different menopausal status. All of three measures met the criteria for known-groups validity. Five measures (WHQ, MQOL, MRS, UQOL, and the MENCAV) evaluated factorial validity, identifying 3 to 10 factors.</p>
</sec>
</sec>
<sec id="section14-0193945911402848">
<title>Responsiveness</title>
<p>As shown in <xref ref-type="table" rid="table6-0193945911402848">Table 6</xref>, five measures (WHQ, MENQOL, MRS, MENQOL-Intervention, and the MENCAV) attempted to assess responsiveness, which is the ability of the instrument to monitor changes in scores over time (<xref ref-type="table" rid="table6-0193945911402848">Table 6</xref>). Among them, the authors of four measures (WHQ, MENQOL, the MENCAV, and MENQOL-Intervention) used effect size statistics, with two (MENQOL and MENQOL-Intervention) reporting values representing moderate levels of responsiveness (i.e., above 0.50). WHQ assessed score changes before and after hormone therapy as well as effect size for changes over time. The MENCAV also reported effect size statistics, but it did not assess changes over time. Rather, it examined magnitude of the age-adjusted effect of menopausal status on the scale scores. The effect size statistics of both WHQ and the MENCAV were not acceptable. The remaining one (MRS) reported sensitivity/specificity as a responsiveness indicator, meeting the criteria.</p>
<table-wrap id="table6-0193945911402848" position="float">
<label>Table 6.</label>
<caption>
<p>Responsiveness and Quality Appraisal Scores for Menopause-Specific QoL Measures</p>
</caption>
<graphic alternate-form-of="table6-0193945911402848" xlink:href="10.1177_0193945911402848-table6.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">WHQ</th>
<th align="center">MRS</th>
<th align="center">MENQOL</th>
<th align="center">MQOL</th>
<th align="center">MENCAV</th>
<th align="center">UQOL</th>
<th align="center">MENQOL-Intervention</th>
</tr>
</thead>
<tbody>
<tr>
<td>Responsiveness</td>
<td>• Significant changes between pre- and posttreatment (estrogen) for total score and each domain</td>
<td>Fits well with the subjective assessment of the hormone treatment effect estimated by the physician (sensitivity: 70.8%, specificity: 73.5%)</td>
<td>Score change over 1 month, responsiveness index = 0.78-1.34 for each domain</td>
<td align="center">—</td>
<td>Difference between menopausal and nonmenopausal women, effect size = 0.45 for total score, 0.07-0.61 for each domain</td>
<td align="center">—</td>
<td>Differences between before and after treatment (14 days), responsiveness index = 1.47 for total score, 0.89-1.39 for each domain</td>
</tr>
<tr>
<td/>
<td>• Clinical change over time, effect size = −0.72 to −0.11 for each domain</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Quality score</td>
<td>2</td>
<td>2</td>
<td>2</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-0193945911402848">
<p>Note: QoL = quality of life; WHQ = Women’s Health Questionnaire; MRS = Menopause Rating Scale; MENQOL = Menopause-specific Quality of Life Questionnaire; MQOL = Menopausal Quality of Life; MENCAV = the MENCAV menopause quality of life scale; UQOL = Utian Quality of Life scale; MENQOL-Intervention = Menopause-specific Quality of Life Questionnaire–Intervention.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section15-0193945911402848">
<title>Quality Scores</title>
<p>Total quality appraisal scores were calculated based on judgments across 10 psychometric criteria (<xref ref-type="table" rid="table2-0193945911402848">Table 2</xref>). The possible maximum quality score for a measure was 20; no measure scored above 14. The highest score was 14 for WHQ. The lowest score was 7 for MENQOL-Intervention. All but one measure (WHQ, MENQOL, MQOL, the MENCAV, UQOL, and MENQOL-Intervention) partially met the reliability criteria, scoring 2 to 4 (possible range: 0-6). The scores based on validity judgment criteria were 3 to 8 for reviewed measures; however, no measures met all the criteria for validity evaluation.</p>
</sec>
</sec>
<sec id="section16-0193945911402848" sec-type="discussion">
<title>Discussion</title>
<p>This systematic review identified and reviewed seven menopause-specific QoL instruments. The psychometric evaluations were conducted based on quality judgment criteria. Three of the seven instruments scored less than 10 (out of a maximum of 20) and no measure met all the criteria for both reliability and validity. This indicates that most instruments of menopause-specific QoL need further testing and evaluation of various aspects of their psychometric properties.</p>
<p>As a result of the review of reliability, most instruments showed good internal consistency, but relatively little attention has been paid to item analysis. Regarding test–retest reliability data, the shorter time interval tended to show higher correlation coefficients between the two measurements. This is a usual result but the length of time between tests is important for the evaluation of test–retest reliability (<xref ref-type="bibr" rid="bibr43-0193945911402848">Polit &amp; Hungler, 1995</xref>). If the two sessions are too close in time, memory effects can influence the second measure, and testing sessions too far apart in time can result in a loss of changes in the variable (<xref ref-type="bibr" rid="bibr53-0193945911402848">Talbot, 1995</xref>). Although a usual time interval for test–retest reliability has been known as 2 weeks, there is no evidence to aid the selection of it (<xref ref-type="bibr" rid="bibr38-0193945911402848">Marx, Menezes, Horovitz, Jones, &amp; Warren, 2003</xref>). Adequate time interval needs to be studied and reconsidered for validation of QoL instruments.</p>
<p>The review of methods used for item generation indicated two critical points. Few measures explicitly stated that items were generated with reference to a conceptual definition or theoretical framework for QoL. This may lead each instrument to measure different aspects of menopause and making it difficult for researchers to compare the study results (<xref ref-type="bibr" rid="bibr17-0193945911402848">Freedman, 2002</xref>; <xref ref-type="bibr" rid="bibr32-0193945911402848">Jacobs et al., 2000</xref>; <xref ref-type="bibr" rid="bibr35-0193945911402848">Li et al., 2000</xref>). Second, it is critical to include menopausal women’s perspectives when determining relevant domains and items (<xref ref-type="bibr" rid="bibr42-0193945911402848">Pearce et al., 2008</xref>). In this review, most reported that their items of the measures were obtained through expert opinions or literature rather than interviews or meetings with menopausal women, with some measures focusing on menopausal symptoms. Undoubtedly, the items reflecting the subjective aspect of QoL can be best extracted from menopausal women themselves. Also, menopause is not a disease. The symptoms may not be universally prevalent in menopausal women (<xref ref-type="bibr" rid="bibr14-0193945911402848">Dennerstein &amp; Helmes, 2000</xref>) and lower levels of the constellation of symptoms in fact may not reflect higher QoL (<xref ref-type="bibr" rid="bibr14-0193945911402848">Dennerstein &amp; Helmes, 2000</xref>).</p>
<p>Most of the psychometric studies reviewed have focused on construct validity with all of the value demonstrating acceptable levels. However, no factorial validity was tested for some measures, and the factor structure of the Italian version of WHQ was inconsistent with that of the original version (<xref ref-type="bibr" rid="bibr44-0193945911402848">Progetto Donna Qualita della Vita Working Group et al., 2002</xref>). This may indicate that women’s cultural beliefs and practices have influences on their menopausal experiences (<xref ref-type="bibr" rid="bibr25-0193945911402848">Hall, Callister, Berry, &amp; Matsumura, 2007</xref>; <xref ref-type="bibr" rid="bibr33-0193945911402848">Lee, Im, &amp; Chee, 2010</xref>). Further psychometric studies for cultural competence as well as for factor structures may improve construct validity of the measures.</p>
<p>Convergent validity is one of the two basic conditions that need to be met for the multitrait–multimethod approach which can determine construct validity (<xref ref-type="bibr" rid="bibr58-0193945911402848">Waltz et al., 2005</xref>). Two basic premises underlying the multitrait–multimethod approach are (a) that different measures of the same construct should correlate highly with each other (convergent validity) and (b) that measures of different constructs should have a low correlation with each other (discriminant validity; <xref ref-type="bibr" rid="bibr58-0193945911402848">Waltz et al., 2005</xref>). Although all measures reviewed established either convergent or discriminant validity, no measure examined both of them simultaneously.</p>
<p>Known-groups validity showed that only two instruments could differentiate among different menopausal status. In this review, however, change patterns of QoL levels across menopausal status have been reported inconsistently; the MENCAV scores of nonmenopausal women were higher than those of menopausal women (<xref ref-type="bibr" rid="bibr5-0193945911402848">Buendia Bermejo et al., 2008</xref>) whereas MQOL scores followed a U-shaped pattern across the menopausal status with the lowest scores achieved in the middle of menopause (<xref ref-type="bibr" rid="bibr32-0193945911402848">Jacobs et al., 2000</xref>). In addition, one of the previous studies reported that there was no significant difference in QoL scores comparing the pre- and perimenopausal women after adjusting for other variables (e.g., age, education level, body mass index, chronic illness; <xref ref-type="bibr" rid="bibr9-0193945911402848">Cheng, Lee, Wang, Wang, &amp; Fuh, 2007</xref>). For more valid and reasonable testing of known-groups validity with menopausal status, QoL changes across menopausal status need to be reassessed and clearly identified in future research, with more consistency in defining and measuring it.</p>
<p>Evaluation of responsiveness may be also important for measuring the concept of QoL because it is not a stable and fixed disposition (<xref ref-type="bibr" rid="bibr41-0193945911402848">Padilla, Mishel, &amp; Grant, 1992</xref>; <xref ref-type="bibr" rid="bibr52-0193945911402848">Schwartz &amp; Rapkin, 2004</xref>). Given it may be susceptible to situational factors and subjective states, QoL instruments should be able to assess the degree and direction of these changes (<xref ref-type="bibr" rid="bibr18-0193945911402848">Garvie et al., 2009</xref>). Although five measures reported responsiveness in this review, the values could not be compared because the study populations and evaluative criterion for changes (e.g., time, treatment) were different. Since responsiveness is related to the potential for clinical improvement, values can only be compared across similar populations (<xref ref-type="bibr" rid="bibr46-0193945911402848">Roy, MacDermid, &amp; Woodhouse, 2009</xref>).</p>
<p>In addition, the QoL instruments reflecting and focusing menopausal women’s subjective experiences (e.g., UQOL, MQOL) seem to lack responsiveness data (<xref ref-type="bibr" rid="bibr56-0193945911402848">Utian et al., 2002</xref>). <xref ref-type="bibr" rid="bibr60-0193945911402848">Wiklund (1998)</xref> also stated that more symptom-based measures had considerably higher values of responsiveness for treatment-induced change. However, the instrument measuring QoL in menopausal women must be sensitive not only to physical but also to psychological, social, sexual, and partner-related changes (<xref ref-type="bibr" rid="bibr5-0193945911402848">Buendia Bermejo et al., 2008</xref>). In addition, it needs to be sensitive in detecting changes because of acute health exacerbations as well as assess changes over the long-term with menopause-related progression (<xref ref-type="bibr" rid="bibr40-0193945911402848">Mishra &amp; Kuh, 2010</xref>; <xref ref-type="bibr" rid="bibr65-0193945911402848">Zöllner et al., 2005</xref>).</p>
<p>This review has strengths including a comprehensive search of the literature and clear guidelines for critical psychometric appraisal. Although the results give valuable insight into psychometric properties of the menopausal QoL instruments, several limitations should be noted. First, relevant studies may have been missed during the search. In addition, this review included only small number of the studies that described psychometric properties. Even though we searched multiple databases, electronic searches are not error free and the review included only papers published in English. Exclusion of gray literature can be a powerful limitation on the validity and value of the review studies (<xref ref-type="bibr" rid="bibr12-0193945911402848">Conn, Valentine, Cooper, &amp; Rantz, 2003</xref>). Second, an absolute psychometric comparison was difficult because study populations and settings of the reviewed papers were various. Even psychometric properties of a same instrument could be different in different studies, populations, or settings (<xref ref-type="bibr" rid="bibr58-0193945911402848">Waltz et al., 2005</xref>). Third, there was difficulty in comparing and evaluating psychometric quality for test–retest reliability because the time interval between the two measurements differed from 3 days to 18 months. Fourth, inconsistent use of terminology regarding validity may have influenced the comparison of data on the validity of each measure. For example, correlations of the reviewed QoL instruments and the measures for the same or similar construct were considered as criterion validity in the MENCAV study (<xref ref-type="bibr" rid="bibr5-0193945911402848">Buendia Bermejo et al., 2008</xref>), concurrent or clinical validity in the WHQ study (<xref ref-type="bibr" rid="bibr31-0193945911402848">Hunter, 1992</xref>; <xref ref-type="bibr" rid="bibr63-0193945911402848">Wool et al., 2000</xref>), and external validity in the UQOL study (<xref ref-type="bibr" rid="bibr56-0193945911402848">Utian et al., 2002</xref>). In this review, we classified them into convergent validity.</p>
<p>It is difficult to recommend one questionnaire over the others due to lack of substantial evidence. One measure may be better for evaluating changes over time or following treatments, whereas another may be better able to discriminate between groups (<xref ref-type="bibr" rid="bibr1-0193945911402848">Alder, 2002</xref>; <xref ref-type="bibr" rid="bibr14-0193945911402848">Dennerstein &amp; Helmes, 2000</xref>; <xref ref-type="bibr" rid="bibr46-0193945911402848">Roy et al., 2009</xref>). Some measures may be taken together to provide a more comprehensive overview of QoL in menopausal women (<xref ref-type="bibr" rid="bibr40-0193945911402848">Mishra &amp; Kuh, 2010</xref>; <xref ref-type="bibr" rid="bibr56-0193945911402848">Utian et al., 2002</xref>; <xref ref-type="bibr" rid="bibr65-0193945911402848">Zöllner et al., 2005</xref>). Although WHQ demonstrated the most extensive psychometric evidence, several issues have been raised with respect to these instruments: “menstrual symptoms” domain may not be applicable to postmenopausal women (<xref ref-type="bibr" rid="bibr21-0193945911402848">Girod, de la Loge, Keininger, &amp; Hunter, 2006</xref>); and there are no data on predictive validity which is one of the three major purposes (discrimination, evaluation, and prediction) of measuring instruments (<xref ref-type="bibr" rid="bibr24-0193945911402848">Guyatt, Feeny, &amp; Patrick, 1993</xref>; <xref ref-type="bibr" rid="bibr50-0193945911402848">Schneider et al., 2008</xref>).</p>
<p>Nevertheless, of the seven measures reviewed in this study, the psychometric quality scores of WHQ was the highest. We recommend that researchers use this instrument to measure QoL in menopausal women, and more data on reliability and validity should be collected for others. Second, all measures reviewed were developed in Europe and North America. Individual menopausal experiences may differ among ethnic groups and it may be inappropriate to use the same QoL measure across ethnicities unless linguistic and cultural adaptation is provided (<xref ref-type="bibr" rid="bibr1-0193945911402848">Alder, 2002</xref>; <xref ref-type="bibr" rid="bibr50-0193945911402848">Schneider et al., 2008</xref>). Future research assessing psychometric properties with cross-cultural samples may be beneficial in adapting measures to specific context and study populations (<xref ref-type="bibr" rid="bibr28-0193945911402848">Herbert, Gagnon, Rennick, &amp; O’Loughlin, 2009</xref>).</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflict of interest with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The author(s) received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0193945911402848">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Alder</surname><given-names>E. M.</given-names></name>
</person-group> (<year>2002</year>). <article-title>How to assess quality of life? Aspects of methodology</article-title>. <conf-name>International Congress Series</conf-name>, <volume>1229</volume>, <fpage>31</fpage>-<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr2-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>K. L.</given-names></name>
<name><surname>Burckhardt</surname><given-names>C. S.</given-names></name>
</person-group> (<year>1999</year>). <article-title>Conceptualization and measurement of quality of life as an outcome variable for health care intervention and research</article-title>. <source>Journal of Advanced Nursing</source>, <volume>29</volume>, <fpage>298</fpage>-<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr3-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barentsen</surname><given-names>R.</given-names></name>
<name><surname>van de Weijer</surname><given-names>P. H. M.</given-names></name>
<name><surname>van Gend</surname><given-names>S.</given-names></name>
<name><surname>Foekema</surname><given-names>H.</given-names></name>
</person-group> (<year>2001</year>). <article-title>Climacteric symptoms in a representative Dutch population sample as measured with the Greene Climacteric Scale</article-title>. <source>Maturitas</source>, <volume>38</volume>, <fpage>123</fpage>-<lpage>128</lpage>.</citation>
</ref>
<ref id="bibr4-0193945911402848">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Brazier</surname><given-names>J. E.</given-names></name>
<name><surname>Roberts</surname><given-names>J.</given-names></name>
<name><surname>Platts</surname><given-names>M.</given-names></name>
<name><surname>Zoellner</surname><given-names>Y. F.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Estimating a preference-based index for a menopause specific health quality of life questionnaire</article-title>. <source>Health and Quality of Life Outcomes</source>, <volume>3</volume>, <fpage>13</fpage>. <comment>Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.hqlo.com/content/3/1/13">http://www.hqlo.com/content/3/1/13</ext-link></comment></citation>
</ref>
<ref id="bibr5-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buendia Bermejo</surname><given-names>J.</given-names></name>
<name><surname>Valverde Martinez</surname><given-names>J. A.</given-names></name>
<name><surname>Romero Saiz</surname><given-names>A.</given-names></name>
<name><surname>Ulla Diez</surname><given-names>S. M.</given-names></name>
<name><surname>Cobo Rodrigo</surname><given-names>A.</given-names></name>
<name><surname>Martinez Vizcaino</surname><given-names>V.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Validation of a menopause quality of life scale: The MENCAV scale</article-title>. <source>Maturitas</source>, <volume>59</volume>, <fpage>28</fpage>-<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr6-0193945911402848">
<citation citation-type="book">
<collab>Center for Reviews and Dissemination</collab>. (<year>2009</year>). <source>Systematic reviews—CRD’s guidance for undertaking reviews in health care</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>University of New York</publisher-name>.</citation>
</ref>
<ref id="bibr7-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chattha</surname><given-names>R.</given-names></name>
<name><surname>Kulkarni</surname><given-names>R.</given-names></name>
<name><surname>Nagarathna</surname><given-names>R.</given-names></name>
<name><surname>Nagendra</surname><given-names>H. R.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Factor analysis of Greene’s Climacteric Scale for Indian women</article-title>. <source>Maturitas</source>, <volume>59</volume>, <fpage>22</fpage>-<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr8-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Lin</surname><given-names>S.-Q.</given-names></name>
<name><surname>Wei</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>H.-L.</given-names></name>
<name><surname>Wu</surname><given-names>Z.-L.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Menopause-specific quality of life satisfaction in community-dwelling menopausal women in China</article-title>. <source>Gynecological Endocrinology</source>, <volume>23</volume>, <fpage>166</fpage>-<lpage>172</lpage>.</citation>
</ref>
<ref id="bibr9-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>M.-H.</given-names></name>
<name><surname>Lee</surname><given-names>S.-J.</given-names></name>
<name><surname>Wang</surname><given-names>S.-J.</given-names></name>
<name><surname>Wang</surname><given-names>P.-H.</given-names></name>
<name><surname>Fuh</surname><given-names>J.-L.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Does menopausal transition affect the quality of life? A longitudinal study of middle-aged women in Kinmen</article-title>. <source>Menopause</source>, <volume>14</volume>, <fpage>885</fpage>-<lpage>890</lpage>.</citation>
</ref>
<ref id="bibr10-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chung</surname><given-names>K. F.</given-names></name>
<name><surname>Tang</surname><given-names>M. K.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Subjective sleep disturbance and its correlates in middle-aged Hong Kong Chinese women</article-title>. <source>Maturitas</source>, <volume>53</volume>, <fpage>396</fpage>-<lpage>404</lpage>.</citation>
</ref>
<ref id="bibr11-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Col</surname><given-names>N. F.</given-names></name>
<name><surname>Haskins</surname><given-names>A. E.</given-names></name>
<name><surname>Ewan-Whyte</surname><given-names>C. J.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Measuring the impact of menopausal symptoms on quality of life: Methodological considerations</article-title>. <source>Menopause</source>, <volume>16</volume>, <fpage>843</fpage>-<lpage>845</lpage>.</citation>
</ref>
<ref id="bibr12-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Conn</surname><given-names>V. S.</given-names></name>
<name><surname>Valentine</surname><given-names>J. C.</given-names></name>
<name><surname>Cooper</surname><given-names>H. M.</given-names></name>
<name><surname>Rantz</surname><given-names>M. J.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Grey literature in meta-analysis</article-title>. <source>Nursing Research</source>, <volume>52</volume>, <fpage>256</fpage>-<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr13-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dennerstein</surname><given-names>L.</given-names></name>
<name><surname>Dudley</surname><given-names>E.</given-names></name>
<name><surname>Burger</surname><given-names>H.</given-names></name>
</person-group> (<year>1997</year>). <article-title>Well-being and the menopausal transition</article-title>. <source>Journal of Psychosomatic Obstetrics &amp; Gynaecology</source>, <volume>18</volume>(<issue>2</issue>), <fpage>95</fpage>-<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr14-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dennerstein</surname><given-names>L.</given-names></name>
<name><surname>Helmes</surname><given-names>E.</given-names></name>
</person-group> (<year>2000</year>). <article-title>The menopausal transition and quality of life: Methodologic issues</article-title>. <source>Quality of Life Research</source>, <volume>9</volume>, <fpage>721</fpage>-<lpage>731</lpage>.</citation>
</ref>
<ref id="bibr15-0193945911402848">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Dinger</surname><given-names>J.</given-names></name>
<name><surname>Zimmermann</surname><given-names>T.</given-names></name>
<name><surname>Heinemann</surname><given-names>L. A. J.</given-names></name>
<name><surname>Stoehr</surname><given-names>D.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Quality of life and hormone use: New validation results of MRS scale</article-title>. <source>Health and Quality of Life Outcomes</source>, <volume>4</volume>, <fpage>32</fpage>. <comment>Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.hqlo.com/content/4/1/32">http://www.hqlo.com/content/4/1/32</ext-link></comment></citation>
</ref>
<ref id="bibr16-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elavsky</surname><given-names>S.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Physical activity, menopause, and quality of life: The role of affect and self-worth across time</article-title>. <source>Menopause</source>, <volume>16</volume>, <fpage>265</fpage>-<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr17-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Freedman</surname><given-names>M. A.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Quality of life and menopause: The role of estrogen</article-title>. <source>Journal of Women’s Health</source>, <volume>11</volume>, <fpage>703</fpage>-<lpage>718</lpage>.</citation>
</ref>
<ref id="bibr18-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garvie</surname><given-names>P. A.</given-names></name>
<name><surname>Lawford</surname><given-names>J.</given-names></name>
<name><surname>Banet</surname><given-names>M. S.</given-names></name>
<name><surname>West</surname><given-names>R. L.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Quality of life measurement in paediatric and adolescent populations with HIV: A review of the literature</article-title>. <source>Child: Care, Health, and Development</source>, <volume>35</volume>, <fpage>440</fpage>-<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr19-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Genazzani</surname><given-names>A. R.</given-names></name>
<name><surname>Nicolucci</surname><given-names>A.</given-names></name>
<name><surname>Campagnoli</surname><given-names>C.</given-names></name>
<name><surname>Crosignani</surname><given-names>P.</given-names></name>
<name><surname>Nappi</surname><given-names>C.</given-names></name>
<name><surname>Serra</surname><given-names>G. B.</given-names></name>
<name><surname>. . . Tempesta</surname><given-names>A.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Validation of Italian version of the Women’s Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers</article-title>. <source>Climacteric</source>, <volume>5</volume>, <fpage>70</fpage>-<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr20-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gharaibeh</surname><given-names>M.</given-names></name>
<name><surname>Al-Obeisat</surname><given-names>S.</given-names></name>
<name><surname>Hattab</surname><given-names>J.</given-names></name>
</person-group> (<year>2010</year>). <article-title>Severity of menopausal symptoms of Jordanian women</article-title>. <source>Climacteric</source>, <volume>13</volume>, <fpage>385</fpage>-<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr21-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Girod</surname><given-names>I.</given-names></name>
<name><surname>de la Loge</surname><given-names>C.</given-names></name>
<name><surname>Keininger</surname><given-names>D.</given-names></name>
<name><surname>Hunter</surname><given-names>M. S.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Development of a revised version of the Women’s Health Questionnaire</article-title>. <source>Climacteric</source>, <volume>9</volume>, <fpage>4</fpage>-<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr22-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grange</surname><given-names>A.</given-names></name>
<name><surname>Bekker</surname><given-names>H.</given-names></name>
<name><surname>Noyes</surname><given-names>J.</given-names></name>
<name><surname>Langley</surname><given-names>P.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Adequacy of health-related quality of life measures in children under 5 years old: Systematic review</article-title>. <source>Journal of Advanced Nursing</source>, <volume>59</volume>, <fpage>197</fpage>-<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr23-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greene</surname><given-names>J. G.</given-names></name>
</person-group> (<year>1998</year>). <article-title>Constructing a standard climacteric scale</article-title>. <source>Maturitas</source>, <volume>29</volume>, <fpage>25</fpage>-<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr24-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guyatt</surname><given-names>G. H.</given-names></name>
<name><surname>Feeny</surname><given-names>D. H.</given-names></name>
<name><surname>Patrick</surname><given-names>D. L.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Measuring health-related quality of life</article-title>. <source>Annals of Internal Medicine</source>, <volume>118</volume>, <fpage>622</fpage>-<lpage>629</lpage>.</citation>
</ref>
<ref id="bibr25-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hall</surname><given-names>L.</given-names></name>
<name><surname>Callister</surname><given-names>L. C.</given-names></name>
<name><surname>Berry</surname><given-names>J. A.</given-names></name>
<name><surname>Matsumura</surname><given-names>G.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Meaning of menopause: Cultural influences on perception and management of menopause</article-title>. <source>Journal of Holistic Nursing</source>, <volume>25</volume>, <fpage>106</fpage>-<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr26-0193945911402848">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Heinemann</surname><given-names>L. A. J.</given-names></name>
<name><surname>DoMinh</surname><given-names>T.</given-names></name>
<name><surname>Strelow</surname><given-names>F.</given-names></name>
<name><surname>Gerbsch</surname><given-names>S.</given-names></name>
<name><surname>Schnitker</surname><given-names>J.</given-names></name>
<name><surname>Schneider</surname><given-names>H. P. G.</given-names></name>
</person-group> (<year>2004</year>). <article-title>The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study</article-title>. <source>Health and Quality of Life Outcomes</source>, <volume>2</volume>, <fpage>67</fpage>. <comment>Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.hqlo.com/content/2/1/67">http://www.hqlo.com/content/2/1/67</ext-link></comment></citation>
</ref>
<ref id="bibr27-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hek</surname><given-names>G.</given-names></name>
<name><surname>Langton</surname><given-names>H.</given-names></name>
<name><surname>Blunden</surname><given-names>G.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Systematically searching and reviewing literature</article-title>. <source>Nurse Researcher</source>, <volume>7</volume>(<issue>3</issue>), <fpage>40</fpage>-<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr28-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Herbert</surname><given-names>R. J.</given-names></name>
<name><surname>Gagnon</surname><given-names>A. J.</given-names></name>
<name><surname>Rennick</surname><given-names>J. E.</given-names></name>
<name><surname>O’Loughlin</surname><given-names>J. L.</given-names></name>
</person-group> (<year>2009</year>). <article-title>A systematic review of questionnaires measuring health-related empowerment</article-title>. <source>Research and Theory for Nursing Practice: An International Journal</source>, <volume>23</volume>, <fpage>107</fpage>-<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr29-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hilditch</surname><given-names>J. R.</given-names></name>
<name><surname>Lewis</surname><given-names>J.</given-names></name>
<name><surname>Peter</surname><given-names>A.</given-names></name>
<name><surname>van Maris</surname><given-names>B.</given-names></name>
<name><surname>Ross</surname><given-names>A.</given-names></name>
<name><surname>Franssen</surname><given-names>E.</given-names></name>
<name><surname>. . . Dunn</surname><given-names>E.</given-names></name>
</person-group> (<year>1996</year>). <article-title>A menopause-specific quality of life questionnaire: Development and psychometric properties</article-title>. <source>Maturitas</source>, <volume>24</volume>, <fpage>161</fpage>-<lpage>175</lpage>.</citation>
</ref>
<ref id="bibr30-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hunt</surname><given-names>S. M.</given-names></name>
</person-group> (<year>2000</year>). <article-title>The subjective health of older women: Measuring outcomes in relation to prevention</article-title>. <source>Quality of Life Research</source>, <volume>9</volume>, <fpage>709</fpage>-<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr31-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hunter</surname><given-names>M.</given-names></name>
</person-group> (<year>1992</year>). <article-title>The Women’s Health Questionnaire: A measure of mid-aged women’s perceptions of their emotional and physical health</article-title>. <source>Psychology and Health</source>, <volume>7</volume>, <fpage>45</fpage>-<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr32-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacobs</surname><given-names>P. A.</given-names></name>
<name><surname>Hyland</surname><given-names>M. E.</given-names></name>
<name><surname>Ley</surname><given-names>A.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Self-rated menopausal status and quality of life in women aged 40-63 years</article-title>. <source>British Journal of Health Psychology</source>, <volume>5</volume>, <fpage>395</fpage>-<lpage>411</lpage>.</citation>
</ref>
<ref id="bibr33-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>B.</given-names></name>
<name><surname>Im</surname><given-names>E.-O.</given-names></name>
<name><surname>Chee</surname><given-names>W.</given-names></name>
</person-group> (<year>2010</year>). <article-title>Psychometric evaluation of the Midlife Women’s Symptom Index in multiethnic groups</article-title>. <source>Western Journal of Nursing Research</source>, <volume>32</volume>, <fpage>1091</fpage>-<lpage>1111</lpage>.</citation>
</ref>
<ref id="bibr34-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>J. E.</given-names></name>
<name><surname>Hilditch</surname><given-names>J. R.</given-names></name>
<name><surname>Wong</surname><given-names>C. J.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire</article-title>. <source>Maturitas</source>, <volume>50</volume>, <fpage>209</fpage>-<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr35-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Holm</surname><given-names>K.</given-names></name>
<name><surname>Gulanick</surname><given-names>M.</given-names></name>
<name><surname>Lanuza</surname><given-names>D.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Perimenopause and the quality of life</article-title>. <source>Clinical Nursing Research</source>, <volume>9</volume>, <fpage>6</fpage>-<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr36-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Llaneza</surname><given-names>P.</given-names></name>
<name><surname>Inarrea</surname><given-names>J.</given-names></name>
<name><surname>Gonzalez</surname><given-names>C.</given-names></name>
<name><surname>Alonso</surname><given-names>A.</given-names></name>
<name><surname>Arnott</surname><given-names>I.</given-names></name>
<name><surname>Ferrer-Barriendos</surname><given-names>J.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Differences in health related quality of life in a sample of Spanish menopausal women with and without obesity</article-title>. <source>Maturitas</source>, <volume>58</volume>, <fpage>387</fpage>-<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr37-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manning-Walsh</surname><given-names>J.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Spiritual struggle: Effect on quality of life and life satisfaction in women with breast cancer</article-title>. <source>Journal of Holistic Nursing</source>, <volume>23</volume>, <fpage>120</fpage>-<lpage>140</lpage>.</citation>
</ref>
<ref id="bibr38-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marx</surname><given-names>R. G.</given-names></name>
<name><surname>Menezes</surname><given-names>A.</given-names></name>
<name><surname>Horovitz</surname><given-names>L.</given-names></name>
<name><surname>Jones</surname><given-names>E. C.</given-names></name>
<name><surname>Warren</surname><given-names>R. F.</given-names></name>
</person-group> (<year>2003</year>). <article-title>A comparison of two time intervals for test-retest reliability of health status instruments</article-title>. <source>Journal of Clinical Epidemiology</source>, <volume>56</volume>, <fpage>730</fpage>-<lpage>735</lpage>.</citation>
</ref>
<ref id="bibr39-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matthews</surname><given-names>K. A.</given-names></name>
<name><surname>Bromberger</surname><given-names>J. T.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Does the menopausal transition affect health-related quality of life?</article-title> <source>American Journal of Medicine</source>, <volume>118</volume>, <fpage>25s</fpage>-<lpage>36s</lpage>.</citation>
</ref>
<ref id="bibr40-0193945911402848">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Mishra</surname><given-names>G. D.</given-names></name>
<name><surname>Kuh</surname><given-names>D.</given-names></name>
</person-group> (<year>2010</year>). <article-title>Quality of life measures during the menopause</article-title>. In <person-group person-group-type="editor">
<name><surname>Preedy</surname><given-names>V. R.</given-names></name>
<name><surname>Watson</surname><given-names>R. R.</given-names></name>
</person-group> (Eds.), <source>Handbook of disease burdens and quality of life measures</source> (pp. <fpage>2593</fpage>-<lpage>2613</lpage>). <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>.</citation>
</ref>
<ref id="bibr41-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Padilla</surname><given-names>G. V.</given-names></name>
<name><surname>Mishel</surname><given-names>M. H.</given-names></name>
<name><surname>Grant</surname><given-names>M. M.</given-names></name>
</person-group> (<year>1992</year>). <article-title>Uncertainty, appraisal, and quality of life</article-title>. <source>Quality of Life Research</source>, <volume>1</volume>, <fpage>155</fpage>-<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr42-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pearce</surname><given-names>N. J. M.</given-names></name>
<name><surname>Sanson-Fisher</surname><given-names>R.</given-names></name>
<name><surname>Campbell</surname><given-names>H. S.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Measuring quality of life in cancer survivors: A methodological review of existing scales</article-title>. <source>Psycho-Oncology</source>, <volume>17</volume>, <fpage>629</fpage>-<lpage>640</lpage>.</citation>
</ref>
<ref id="bibr43-0193945911402848">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Polit</surname><given-names>D. F.</given-names></name>
<name><surname>Hungler</surname><given-names>B. P.</given-names></name>
</person-group> (<year>1995</year>). <source>Nursing research: Principles and methods</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>J. B. Lippincott</publisher-name>.</citation>
</ref>
<ref id="bibr44-0193945911402848">
<citation citation-type="journal">
<collab>Progetto Donna Qualita della Vita Working Group</collab>, <person-group person-group-type="author">
<name><surname>Genazzani</surname><given-names>A. R.</given-names></name>
<name><surname>Nicolucci</surname><given-names>A.</given-names></name>
<name><surname>Campagnoli</surname><given-names>C.</given-names></name>
<name><surname>Crosignani</surname><given-names>P.</given-names></name>
<name><surname>Nappi</surname><given-names>C.</given-names></name>
<name><surname>. . . Coronel</surname><given-names>G. A.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users</article-title>. <source>Maturitas</source>, <volume>42</volume>, <fpage>267</fpage>-<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr45-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pudas-Tahka</surname><given-names>S.-M.</given-names></name>
<name><surname>Axelin</surname><given-names>A.</given-names></name>
<name><surname>Aantaa</surname><given-names>R.</given-names></name>
<name><surname>Lund</surname><given-names>V.</given-names></name>
<name><surname>Salantera</surname><given-names>S.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Pain assessment tools for unconscious or sedated intensive care patients: A systematic review</article-title>. <source>Journal of Advanced Nursing</source>, <volume>65</volume>, <fpage>946</fpage>-<lpage>956</lpage>.</citation>
</ref>
<ref id="bibr46-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roy</surname><given-names>J.-S.</given-names></name>
<name><surname>MacDermid</surname><given-names>J. C.</given-names></name>
<name><surname>Woodhouse</surname><given-names>L. J.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Measuring shoulder function: A systematic review of four questionnaires</article-title>. <source>Arthritis &amp; Rheumatism</source>, <volume>61</volume>, <fpage>623</fpage>-<lpage>632</lpage>.</citation>
</ref>
<ref id="bibr47-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>H. P. G.</given-names></name>
</person-group> (<year>2002</year>). <article-title>The quality of life in the postmenopausal woman</article-title>. <source>Best Practice &amp; Research: Clinical Obstetrics &amp; Gynecology</source>, <volume>16</volume>, <fpage>395</fpage>-<lpage>409</lpage>.</citation>
</ref>
<ref id="bibr48-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>H. P. G.</given-names></name>
<name><surname>Heinemann</surname><given-names>L. A. J.</given-names></name>
<name><surname>Rosemeier</surname><given-names>H.-P.</given-names></name>
<name><surname>Potthoff</surname><given-names>P.</given-names></name>
<name><surname>Behre</surname><given-names>H. M.</given-names></name>
</person-group> (<year>2000a</year>). <article-title>The Menopause Rating Scale (MRS): Reliability of scores of menopausal complaints</article-title>. <source>Climacteric</source>, <volume>3</volume>, <fpage>59</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr49-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>H. P. G.</given-names></name>
<name><surname>Heinemann</surname><given-names>L. A. J.</given-names></name>
<name><surname>Rosemeier</surname><given-names>H.-P.</given-names></name>
<name><surname>Potthoff</surname><given-names>P.</given-names></name>
<name><surname>Behre</surname><given-names>H. M.</given-names></name>
</person-group> (<year>2000b</year>). <article-title>The Menopause Rating Scale (MRS): Comparison with Kupperman index and quality-of-life scale SF-36</article-title>. <source>Climacteric</source>, <volume>3</volume>, <fpage>50</fpage>-<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr50-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>H. P. G.</given-names></name>
<name><surname>MacLennan</surname><given-names>A. H.</given-names></name>
<name><surname>Feeny</surname><given-names>D.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Assessment of health-related quality of life in menopause and aging</article-title>. <source>Climacteric</source>, <volume>11</volume>, <fpage>93</fpage>-<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr51-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>H. P. G.</given-names></name>
<name><surname>Rosemeier</surname><given-names>H. P.</given-names></name>
<name><surname>Schnitker</surname><given-names>J.</given-names></name>
<name><surname>Gerbsch</surname><given-names>S.</given-names></name>
<name><surname>Turck</surname><given-names>R.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Application and factor analysis of the menopause rating scale (MRS) in a post-marketing surveillance study of Climen</article-title>. <source>Maturitas</source>, <volume>37</volume>, <fpage>113</fpage>-<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr52-0193945911402848">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Schwartz</surname><given-names>C. E.</given-names></name>
<name><surname>Rapkin</surname><given-names>B. D.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal</article-title>. <source>Health and Quality of Life Outcomes</source>, <volume>2</volume>, <fpage>16</fpage>. <comment>Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.hqlo.com/content/2/1/16">http://www.hqlo.com/content/2/1/16</ext-link></comment></citation>
</ref>
<ref id="bibr53-0193945911402848">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Talbot</surname><given-names>L. A.</given-names></name>
</person-group> (<year>1995</year>). <source>Principles and practice of nursing research</source>. <publisher-loc>St. Louis, MO</publisher-loc>: <publisher-name>Mosby</publisher-name>.</citation>
</ref>
<ref id="bibr54-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Travers</surname><given-names>C.</given-names></name>
<name><surname>O’Neill</surname><given-names>M. O.</given-names></name>
<name><surname>King</surname><given-names>R.</given-names></name>
<name><surname>Battistutta</surname><given-names>D.</given-names></name>
<name><surname>Khoo</surname><given-names>S. K.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Greene Climacteric Scale: Norms in an Australian population in relation to age and menopausal status</article-title>. <source>Climacteric</source>, <volume>8</volume>, <fpage>56</fpage>-<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr55-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Utian</surname><given-names>W. H.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Quality of life (QOL) in menopause</article-title>. <source>Maturitas</source>, <volume>57</volume>, <fpage>100</fpage>-<lpage>102</lpage>.</citation>
</ref>
<ref id="bibr56-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Utian</surname><given-names>W. H.</given-names></name>
<name><surname>Janata</surname><given-names>J. W.</given-names></name>
<name><surname>Kingsberg</surname><given-names>S. A.</given-names></name>
<name><surname>Schluchter</surname><given-names>M.</given-names></name>
<name><surname>Hamilton</surname><given-names>J. C.</given-names></name>
</person-group> (<year>2002</year>). <article-title>The Utian Quality of Life (UQOL) Scale: Development and validation of an instrument to quantify quality of life through and beyond menopause</article-title>. <source>Menopause</source>, <volume>9</volume>, <fpage>402</fpage>-<lpage>410</lpage>.</citation>
</ref>
<ref id="bibr57-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Saane</surname><given-names>N.</given-names></name>
<name><surname>Sluiter</surname><given-names>J. K.</given-names></name>
<name><surname>Verbeek</surname><given-names>J. H. A. M.</given-names></name>
<name><surname>Frings-Dresen</surname><given-names>M. H. W.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Reliability and validity of instruments measuring job satisfaction—A systematic review</article-title>. <source>Occupational Medicine</source>, <volume>53</volume>, <fpage>191</fpage>-<lpage>200</lpage>.</citation>
</ref>
<ref id="bibr58-0193945911402848">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Waltz</surname><given-names>C. F.</given-names></name>
<name><surname>Strickland</surname><given-names>O. L.</given-names></name>
<name><surname>Lenz</surname><given-names>E. R.</given-names></name>
</person-group> (<year>2005</year>). <source>Measurement in nursing and health research</source> (<edition>3rd ed.</edition>). <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>.</citation>
</ref>
<ref id="bibr59-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Whiting</surname><given-names>L. S.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Systematic review protocols: An introduction</article-title>. <source>Nurse Researcher</source>, <volume>17</volume>(<issue>1</issue>), <fpage>34</fpage>-<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr60-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wiklund</surname><given-names>I.</given-names></name>
</person-group> (<year>1998</year>). <article-title>Methods of assessing the impact of climacteric complaints on quality of life</article-title>. <source>Maturitas</source>, <volume>29</volume>, <fpage>41</fpage>-<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr61-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wiklund</surname><given-names>I.</given-names></name>
<name><surname>Berg</surname><given-names>G.</given-names></name>
<name><surname>Hammar</surname><given-names>M.</given-names></name>
<name><surname>Karlberg</surname><given-names>J.</given-names></name>
<name><surname>Lidgren</surname><given-names>R.</given-names></name>
<name><surname>Sandin</surname><given-names>K.</given-names></name>
</person-group> (<year>1992</year>). <article-title>Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women</article-title>. <source>Maturitas</source>, <volume>14</volume>, <fpage>225</fpage>-<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr62-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Woods</surname><given-names>N. F.</given-names></name>
</person-group> (<year>2010</year>). <article-title>Menopause, symptoms, and quality of life: Time for a theoretical framework</article-title>. <source>Menopause</source>, <volume>17</volume>, <fpage>892</fpage>-<lpage>893</lpage>.</citation>
</ref>
<ref id="bibr63-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wool</surname><given-names>C.</given-names></name>
<name><surname>Cerutti</surname><given-names>R.</given-names></name>
<name><surname>Marquis</surname><given-names>P.</given-names></name>
<name><surname>Cialdella</surname><given-names>P.</given-names></name>
<name><surname>Hervie</surname><given-names>C.</given-names></name>
</person-group>, &amp; <collab>Italian Study Group on Quaity of Life</collab>. (<year>2000</year>). <article-title>Psychometric validation of two Italian quality of life questionnaires in menopausal women</article-title>. <source>Maturitas</source>, <volume>35</volume>, <fpage>129</fpage>-<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr64-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yan</surname><given-names>H.</given-names></name>
<name><surname>Sellick</surname><given-names>K.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Symptoms, psychological distress, social support, and quality of life of Chinese patients newly diagnosed with gastrointestinal cancer</article-title>. <source>Cancer Nursing</source>, <volume>27</volume>, <fpage>389</fpage>-<lpage>399</lpage>.</citation>
</ref>
<ref id="bibr65-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zöllner</surname><given-names>Y. F.</given-names></name>
<name><surname>Acquadro</surname><given-names>C.</given-names></name>
<name><surname>Schaefer</surname><given-names>M.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Literature review of instruments to assess health-related quality of life during and after menopause</article-title>. <source>Quality of Life Research</source>, <volume>14</volume>, <fpage>309</fpage>-<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr66-0193945911402848">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zwakhalen</surname><given-names>S. M. G.</given-names></name>
<name><surname>Hamers</surname><given-names>J. P. H.</given-names></name>
<name><surname>Abu-Saad</surname><given-names>H. H.</given-names></name>
<name><surname>Berger</surname><given-names>M. P. F.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Pain in elderly people with severe dementia: A systematic review of behavioral pain assessment tools</article-title>. <source>BMC Geriatrics</source>, <volume>6</volume>, <fpage>3</fpage>. doi:10.1186/1471-2318-6-3<pub-id pub-id-type="doi">10.1186/1471-2318-6-3</pub-id></citation>
</ref>
</ref-list>
</back>
</article>